European Commission provides additional doses of Remdesivitri

The European Commission announced today that it has provided additional supplies of the Remdesiviriral medicine, approved to treat COVID-19, for up to 500,000 patients. “Dozas will be purchased through a joint contract for the 27 EU nations, plus Norway, Iceland, Great Britain, along with six other countries that are candidates [...]
The European Commission announced today that it has provided additional supplies of the Remdesiviriral medicine, approved to treat COVID-19, for up to 500,000 patients.
“Dozas will be purchased through a joint contract for the 27 EU nations, plus Norway, Iceland, Great Britain, along with six other countries that are potential candidates or candidates for admission to Block”, the EC said, the ATS.
Places can now make their orders to take the medicine.
Remdesivir is the first drug to have received the EU's approval to handle serious cases of COVID-19, the disease caused by the new coronary.











